Zeta Pharma

Zeta Pharma company information, Employees & Contact Information

Explore related pages

Related company profiles:

Zeta pharma is a promising pharmaceutical company, launched in 2010 . Zeta pharma has it's own manufacturing facility with the latest production technology located in SADAT city, Egypt . Zeta VISION we are aiming to be one of the leading companies in pharmaceutical industry in EGYPT & MIDDLE EAST, working side by side with Healthcare providers to improve patients’ quality of life and contribute in building a healthy community able to face upcoming challenges. Zeta Mission Serving our patients to live a healthy life through providing them with latest medications in different therapeutic areas, striving to set a new benchmark in pharmaceutical industry under the umbrella of Zeta values which inspire our professional employees for outstanding performance that qualifies Zeta pharma to be your trusted partner.

Company Details

Employees
621
Founded
-
Address
36 Mohamed Al Nady Street,nasr City-Cairo, Cairo,nasr City 12155,egypt
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Cairo, Nasr city
Looking for a particular Zeta Pharma employee's phone or email?

Zeta Pharma Questions

News

ZETA - Pharmaceutical Technology

ZETA Pharmaceutical Technology

AbelZeta Announces Late-Breaking Poster Presentation at ACR Convergence 2025 of First-in-Human Phase I Trial of anti-CD20/BCMA Bispecific CAR-T Therapy in Patients with Refractory Autoimmune Diseases - PR Newswire

AbelZeta Announces Late-Breaking Poster Presentation at ACR Convergence 2025 of First-in-Human Phase I Trial of anti-CD20/BCMA Bispecific CAR-T Therapy in Patients with Refractory Autoimmune Diseases PR Newswire

Zeta Biopharma or how the EU's Risk Sharing Instrument Translates into Innovation and Growth - European Commission

Zeta Biopharma or how the EU's Risk Sharing Instrument Translates into Innovation and Growth European Commission

Zeta Acquires 20% Stake in CB Consultancy - CHEManager

Zeta Acquires 20% Stake in CB Consultancy CHEManager

Vertex, Saudi Arabia ink memorandum of understanding to boost local gene therapy manufacturing - Fierce Pharma

Vertex, Saudi Arabia ink memorandum of understanding to boost local gene therapy manufacturing Fierce Pharma

ZETA opens cleanroom design-build subsidiary in Poland - Cleanroom Technology

ZETA opens cleanroom design-build subsidiary in Poland Cleanroom Technology

Stability indicating RP-HPLC technique for simultaneous estimation of nirmatrelvir and ritonavir in their new copackaged dosage form for COVID-19 treatment - Nature

Stability indicating RP-HPLC technique for simultaneous estimation of nirmatrelvir and ritonavir in their new copackaged dosage form for COVID-19 treatment Nature

AbelZeta Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for C-CAR168 for the Treatment of Refractory SLE, Including LN - PR Newswire

AbelZeta Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for C-CAR168 for the Treatment of Refractory SLE, Including LN PR Newswire

CBMG Holdings Announces Name Change to AbelZeta Pharma, Inc. - BioSpace

CBMG Holdings Announces Name Change to AbelZeta Pharma, Inc. BioSpace

AbelZeta, Janssen Amend CAR-T Deal - Contract Pharma

AbelZeta, Janssen Amend CAR-T Deal Contract Pharma

Innovative Buffer Management Solutions: ZETA’s Modular Buffer Inline Conditioning System - Pharmaceutical Technology

Innovative Buffer Management Solutions: ZETA’s Modular Buffer Inline Conditioning System Pharmaceutical Technology

Austrian-based ZETA Group Invests in Pennsylvania - PA Department of Community & Economic Development (.gov)

Austrian-based ZETA Group Invests in Pennsylvania PA Department of Community & Economic Development (.gov)

CPHI Middle East facilitates $798mln deals in Saudi pharma sector - ZAWYA

CPHI Middle East facilitates $798mln deals in Saudi pharma sector ZAWYA

Internationally Active ZETA Group Acquires a Stake in Biotree, India - Pharmaceutical Technology

Internationally Active ZETA Group Acquires a Stake in Biotree, India Pharmaceutical Technology

AbelZeta Pharma Announces Agreement with AstraZeneca to Co-Develop a novel Glypican 3 (GPC3) Armored CAR-T Therapy in China - PR Newswire

AbelZeta Pharma Announces Agreement with AstraZeneca to Co-Develop a novel Glypican 3 (GPC3) Armored CAR-T Therapy in China PR Newswire

ZETA USA: A Rising Champion in Biopharmaceutical Aseptic Processes and Automation for North America - Pharmaceutical Technology

ZETA USA: A Rising Champion in Biopharmaceutical Aseptic Processes and Automation for North America Pharmaceutical Technology

AbelZeta Presents Data from Two Clinical Studies Relating to its Immuno-Oncology Drug Development at the 65th ASH Annual Meeting - PR Newswire

AbelZeta Presents Data from Two Clinical Studies Relating to its Immuno-Oncology Drug Development at the 65th ASH Annual Meeting PR Newswire

AbelZeta and AstraZeneca enter CAR-T cell therapy development deal - Pharmaceutical Technology

AbelZeta and AstraZeneca enter CAR-T cell therapy development deal Pharmaceutical Technology

AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024 - PR Newswire

AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024 PR Newswire

Cellular Biomedicine draws a line under its past | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Cellular Biomedicine draws a line under its past | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

AbelZeta Presents New Data on C-CAR168 for the Treatment of Autoimmune Diseases at LUPUS 2025 - BioSpace

AbelZeta Presents New Data on C-CAR168 for the Treatment of Autoimmune Diseases at LUPUS 2025 BioSpace

LGM Pharma Buys Nexgen Assets - CHEManager

LGM Pharma Buys Nexgen Assets CHEManager

Drap chief accused of running pharma firm - Dawn

Drap chief accused of running pharma firm Dawn

Romania clears Diamedix Impex takeover by Emma Zeta - SeeNews

Romania clears Diamedix Impex takeover by Emma Zeta SeeNews

Drap CEO asked to explain ‘misuse of power’ - Dawn

Drap CEO asked to explain ‘misuse of power’ Dawn

Top Zeta Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant